Related Experiment Video
Updated: Aug 14, 2026
16:08
Brain Imaging Investigation of the Impairing Effect of Emotion on Cognition
Published on: February 1, 2012
16.2K
Distractor suppression does and does not depend on pre-distractor alpha-band activity
Biorxiv : the Preprint Server for Biology
|July 28, 2023
Summary
Strategic use of spatial cues speeds distractor suppression, enhancing target detection. Foreknowledge of distractor location facilitates suppression independently of alpha-band activity, highlighting pre-stimulus neural processes.
Area of Science:
- Cognitive Neuroscience
- Neuroscience
- Psychology
Background:
- Selective attention involves enhancing important information and suppressing distractors.
- Research has focused more on sensory enhancement than suppression.
- Debate exists on whether suppression can occur independently of enhancement and before distractor onset.
Approach:
- Utilized electroencephalography (EEG) and behavioral measures during a visual search task.
- Investigated alpha power (∼8-15 Hz) and distractor positivity (P$_{D}$) as markers of suppression.
- Examined the effects of spatial cues indicating upcoming distractor locations.
Key Points:
- Cueing distractor locations sped up responses and led to earlier P$_{D}$ onset, indicating proactive suppression.
- Higher pre-distractor alpha power correlated with successful suppression, but was not consistently modulated by spatial cues.
- Cueing effects on behavior and neural measures were independent of alpha-power-related sensory gating.
Conclusions:
- Spatial cues enable proactive distractor suppression before distractor appearance.
- Successful suppression can occur independently of alpha-band activity modulation.
- Pre-stimulus neural processes are crucial for effective distractor suppression.
More Related Videos
Related Concept Videos
02:18Interference and Diffraction
Interference is a characteristic phenomenon exhibited by waves. When two electromagnetic waves interact with their peaks and troughs coinciding, a resulting wave with enhanced amplitude is produced. This is known as constructive interference. In this case, the two waves interacting are in phase with each other.
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:17Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...